WO2005079814A1 - Composition pharmaceutique utilisee pour le traitement de l'avortement spontane recurrent et procede associe - Google Patents
Composition pharmaceutique utilisee pour le traitement de l'avortement spontane recurrent et procede associe Download PDFInfo
- Publication number
- WO2005079814A1 WO2005079814A1 PCT/CN2004/000135 CN2004000135W WO2005079814A1 WO 2005079814 A1 WO2005079814 A1 WO 2005079814A1 CN 2004000135 W CN2004000135 W CN 2004000135W WO 2005079814 A1 WO2005079814 A1 WO 2005079814A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- chromosome
- pharmaceutical composition
- rsa
- male individuals
- fibronectin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2004/000135 WO2005079814A1 (fr) | 2004-02-20 | 2004-02-20 | Composition pharmaceutique utilisee pour le traitement de l'avortement spontane recurrent et procede associe |
AT04712990T ATE441422T1 (de) | 2004-02-20 | 2004-02-20 | Pharmazeutische zusammensetzung zur behandlung von wiederholt auftretendem spontanabort und verfahren dafür |
CNA2004800299183A CN1867342A (zh) | 2004-02-20 | 2004-02-20 | 反复自然流产的治疗药物及治疗方法 |
EP04712990A EP1719516B1 (en) | 2004-02-20 | 2004-02-20 | A pharmaceutical composition used for treating recurrent spontaneous abortion and method thereof |
US10/585,623 US7902162B2 (en) | 2004-02-20 | 2004-02-20 | Medicament and method for treating recurrent spontaneous abortion |
DE602004022993T DE602004022993D1 (de) | 2004-02-20 | 2004-02-20 | Pharmazeutische zusammensetzung zur behandlung von wiederholt auftretendem spontanabort und verfahren dafür |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2004/000135 WO2005079814A1 (fr) | 2004-02-20 | 2004-02-20 | Composition pharmaceutique utilisee pour le traitement de l'avortement spontane recurrent et procede associe |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005079814A1 true WO2005079814A1 (fr) | 2005-09-01 |
Family
ID=34876878
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2004/000135 WO2005079814A1 (fr) | 2004-02-20 | 2004-02-20 | Composition pharmaceutique utilisee pour le traitement de l'avortement spontane recurrent et procede associe |
Country Status (6)
Country | Link |
---|---|
US (1) | US7902162B2 (zh) |
EP (1) | EP1719516B1 (zh) |
CN (1) | CN1867342A (zh) |
AT (1) | ATE441422T1 (zh) |
DE (1) | DE602004022993D1 (zh) |
WO (1) | WO2005079814A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111254111A (zh) * | 2020-02-29 | 2020-06-09 | 贵州医科大学 | 靶向治疗习惯性流产和免疫性不孕的细胞及其制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2836362A1 (de) * | 1978-08-19 | 1980-03-06 | Behringwerke Ag | Diagnostisches mittel |
WO1983000877A1 (en) * | 1981-08-31 | 1983-03-17 | Icl Scient | Glucose oxidase immunohistochemical detection of antinuclear antibodies |
US5281522A (en) * | 1988-09-15 | 1994-01-25 | Adeza Biomedical Corporation | Reagents and kits for determination of fetal fibronectin in a vaginal sample |
US5468619A (en) * | 1991-11-04 | 1995-11-21 | Adeza Biomedical Corporation | Screening method for identifying women at increased risk for imminent delivery |
JPH09218202A (ja) * | 1995-12-08 | 1997-08-19 | B M L:Kk | 抗核抗体の検出方法及び検出用キット |
WO2002042769A1 (fr) * | 2000-11-22 | 2002-05-30 | Matsuura, Eiji | Procede de detection d'un anticorps anti-laminine-1 et sa mise en application |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4444879A (en) | 1981-01-29 | 1984-04-24 | Science Research Center, Inc. | Immunoassay with article having support film and immunological counterpart of analyte |
CA2358146A1 (en) | 2001-09-19 | 2003-03-19 | Leila Bocksch | A method of inhibiting immunologically mediated abortions |
-
2004
- 2004-02-20 CN CNA2004800299183A patent/CN1867342A/zh active Pending
- 2004-02-20 DE DE602004022993T patent/DE602004022993D1/de not_active Expired - Lifetime
- 2004-02-20 EP EP04712990A patent/EP1719516B1/en not_active Expired - Lifetime
- 2004-02-20 US US10/585,623 patent/US7902162B2/en active Active - Reinstated
- 2004-02-20 WO PCT/CN2004/000135 patent/WO2005079814A1/zh active Application Filing
- 2004-02-20 AT AT04712990T patent/ATE441422T1/de not_active IP Right Cessation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2836362A1 (de) * | 1978-08-19 | 1980-03-06 | Behringwerke Ag | Diagnostisches mittel |
WO1983000877A1 (en) * | 1981-08-31 | 1983-03-17 | Icl Scient | Glucose oxidase immunohistochemical detection of antinuclear antibodies |
US5281522A (en) * | 1988-09-15 | 1994-01-25 | Adeza Biomedical Corporation | Reagents and kits for determination of fetal fibronectin in a vaginal sample |
US5468619A (en) * | 1991-11-04 | 1995-11-21 | Adeza Biomedical Corporation | Screening method for identifying women at increased risk for imminent delivery |
JPH09218202A (ja) * | 1995-12-08 | 1997-08-19 | B M L:Kk | 抗核抗体の検出方法及び検出用キット |
WO2002042769A1 (fr) * | 2000-11-22 | 2002-05-30 | Matsuura, Eiji | Procede de detection d'un anticorps anti-laminine-1 et sa mise en application |
Non-Patent Citations (2)
Title |
---|
KANO TAKASHI ET AL: "The incidence of endometriosis and adenomyosis in patients with Habitual abortion in relation to immunological abnormalities.", NIPPON SANKA FUJINKA GAKKAI ZASSHI, vol. 42, no. 2, 1997, pages 113 - 118, XP008084812 * |
OGASAWARA MAYUMI ET AL: "Clinical significance of beta2 glycoprotein I dependent Anticardiolipin antibody, lupus anticoagulant and antinuclear antibidies in patients with Recurrent miscarriages.", REPRODUCTIVE IMMUNOLOGY., October 1998 (1998-10-01), pages 272 - 276, XP008079514 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111254111A (zh) * | 2020-02-29 | 2020-06-09 | 贵州医科大学 | 靶向治疗习惯性流产和免疫性不孕的细胞及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
US7902162B2 (en) | 2011-03-08 |
ATE441422T1 (de) | 2009-09-15 |
EP1719516B1 (en) | 2009-09-02 |
US20090131345A1 (en) | 2009-05-21 |
DE602004022993D1 (de) | 2009-10-15 |
EP1719516A4 (en) | 2007-03-28 |
CN1867342A (zh) | 2006-11-22 |
EP1719516A1 (en) | 2006-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wang et al. | Th17/Treg‑cell balance in the peripheral blood of pregnant females with a history of recurrent spontaneous abortion receiving progesterone or cyclosporine A | |
Shen et al. | Baicalin is curative against rotavirus damp heat diarrhea by tuning colonic mucosal barrier and lung immune function | |
JP2016538333A (ja) | ヒトパピローマウイルス治療ワクチン | |
CN114517226A (zh) | Axl作为宫腔粘连诊断和治疗靶点的应用 | |
WO2012083884A1 (zh) | 红色诺卡氏菌细胞壁骨架增强树突状细胞功能的方法 | |
KR100617485B1 (ko) | 파필로마바이러스 감염의 치료 | |
WO2005079814A1 (fr) | Composition pharmaceutique utilisee pour le traitement de l'avortement spontane recurrent et procede associe | |
Zammarchi et al. | Valacyclovir for prevention and treatment of fetal CMV infection: inclusion in the Law 648/96 list and launch of the Italian multicentre observational prospective study “MEGAL-ITALI” | |
CN102657876B (zh) | 免疫性习惯性流产的药物治疗及检测方法 | |
CN102657877B (zh) | 免疫性习惯性流产的检查及监测方法 | |
CN111001016B (zh) | 一种vha抑制dr5在缺氧下精子生成减少的检测方法 | |
CN115137715A (zh) | 一种姜黄素在制备治疗早发性卵巢功能不全及卵巢响应匮乏药物中的应用 | |
US20210284946A1 (en) | Tumour immunogen, preparation method therefor, and application | |
Aslanian-Kalkhoran et al. | The effect of lymphocyte immunotherapy (LIT) in modulating immune responses in patients with recurrent pregnancy loss (RPL) | |
US7674590B2 (en) | Methods for diagnosing and for monitoring the treatment of recurrent spontaneous abortion | |
Shulman et al. | ANTIBODIES TO SPERMATOZOA | |
Houwert-de Jong et al. | The natural course of habitual abortion | |
Mugdha et al. | Role of immunomodulation with lymphocyte immunization therapy (LIT) in a couple with 15 unexplained repeated miscarriages | |
Daboubi | Anticardiolipin antibodies in women with recurrent abortion | |
US20230338490A1 (en) | Canine cancer vaccine | |
Sun et al. | Complex TNF-α B cell epitope MAP vaccine alleviates murine ulcerative colitis | |
US20150010584A1 (en) | Targeted Delivery Of Autoantigens To B Cell Populations | |
Ilieva¹ et al. | Round immature spermatogenic cells in semen fluids of infertile men with diagnosis “migrating testis”. Two casuistic cases in adults | |
CN116421718A (zh) | 人源抗proBDNF单克隆抗体的应用 | |
Wu et al. | A study of protective effects of Mus81 in preeclampsia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200480029918.3 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 10585623 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004712990 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2004712990 Country of ref document: EP |